🇺🇸 FDA
Patent

US 9346867

Cancer-related glycopeptide epitopes, antibodies and methods of use

granted A61PA61P35/00A61P37/04

Quick answer

US patent 9346867 (Cancer-related glycopeptide epitopes, antibodies and methods of use) held by SUMITOMO BAKELITE CO., LTD. expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUMITOMO BAKELITE CO., LTD.
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00, A61P37/04